Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.1M Buy
36,100
+400
+1% +$47.5K 0.09% 227
2024
Q2
$4.42M Sell
35,700
-13,700
-28% -$1.76M 0.08% 222
2024
Q1
$6.52M Buy
49,400
+16,500
+50% +$2.03M 0.16% 132
2023
Q4
$3.59M Buy
32,900
+17,900
+119% +$1.86M 0.11% 162
2023
Q3
$1.54M Sell
15,000
-3,400
-18% -$366K 0.04% 261
2023
Q2
$2.12M Sell
18,400
-73,900
-80% -$8.39M 0.07% 188
2023
Q1
$9.82M Buy
+92,300
New +$9.97M 0.79% 29

Other funds holding MRK

Eisler Capital (US)'s MRK Position: Q3 2024 in Review

Eisler Capital (US) sold out of Merck (MRK) in Q3 2024, closing a stake of 8,107 shares — an estimated $963K sold.

Eisler Capital (US) first reported a position in MRK in Q2 2024 and held it in 1 quarter. The position peaked at $1M in Q2 2024. 3,492 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Eisler Capital (US) reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 8,107 Merck shares in Q3 2024, an estimated $963K.
  • Eisler Capital (US) first reported a position in Merck in Q2 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s Merck position peaked at $1M in Q2 2024.
  • 3,492 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.